Real-time enrollment status for this chemotherapy-induced nausea and vomiting clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:02 PM UTC
| NCT Number | NCT07169851 |
| Recruiting Status | Recruiting |
| Condition | Chemotherapy-Induced Nausea and Vomiting |
| Phase | PHASE2 |
| Target Enrollment | 204 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | October 8, 2026 (4 days ago) |
As of October 12, 2026: Clinical trial NCT07169851 is currently recruiting participants. This phase2 study for chemotherapy-induced nausea and vomiting is actively seeking new participants at 20 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07169851 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07169851 was last updated 4 days ago (October 8, 2026). HelloStudys verifies this status automatically.